Cargando…
Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis
Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), is expressed on osteoblasts (OB) and hematopoietic stem cells (HSC) residing in the hematopoietic niche, and may have important regulatory roles in bone formation. Because HSC numbers are reduced 77% in CD166(-/-) mice, we hypothesized that c...
Autores principales: | Hooker, R.A., Chitteti, B.R., Egan, P.H., Cheng, Y-H., Himes, E.R., Meijome, T., Srour, E.F., Fuchs, R.K., Kacena, M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Musculoskeletal and Neuronal Interactions
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439374/ https://www.ncbi.nlm.nih.gov/pubmed/25730656 |
Ejemplares similares
-
ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer
por: Tachezy, Michael, et al.
Publicado: (2012) -
ANGI-03 Functional roles of CD166/activated leukocyte cell adhesion molecule (CD166/ALCAM) for glioblastoma invasion
por: Kijima, Noriyuki, et al.
Publicado: (2020) -
The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
por: Yang, Yiming, et al.
Publicado: (2021) -
Expression Levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in Primary Breast Carcinoma and Distant Breast Cancer Metastases
por: Ihnen, M., et al.
Publicado: (2010) -
Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer
por: Tan, Fang, et al.
Publicado: (2014)